#peptidecdmo — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #peptidecdmo, aggregated by home.social.
-
Samsung Biologics Acquires PolyPeptide for 2.7 Trillion Won, Expanding Growth Axis Beyond Antibodies
PolyPeptide Group’s India (Ambernath) plant. Photo courtesy of Samsung Biologics Samsung Biologics’ (207940.KS) acquisition of Swiss peptide contract…
#EuropeSays #Korea #KR #SamsungBiologics #biopharmaceuticalM&A #GLP-1 #Koreabiotech #NHInvestment&Securities #obesitytreatment #PeptideCDMO #PolyPeptide #Samsung
https://www.europesays.com/korea/92946/ -
Samsung Biologics Acquires Swiss Peptide CDMO PolyPeptide Group for approximately $1.8 Billion — BigGo Finance
Samsung Biologics (207940) has placed a major bet on capturing the global peptide contract development and manufacturing organization…
#EuropeSays #Korea #KR #Samsung #DraupnirHolding #GLP-1 #ObesityTreatments #PeptideCDMO #PolyPeptideGroup #SamsungBiologics #SamsungGroup #Switzerland
https://www.europesays.com/korea/92708/ -
https://www.europesays.com/ch/105743/ Samsung Biologics Acquires Swiss Peptide CDMO PolyPeptide Group for approximately $1.8 Billion — BigGo Finance #DraupnirHolding #GLP1 #ObesityTreatments #PeptideCDMO #PolyPeptideGroup #Samsung #SamsungBiologics #Swiss #Switzerland
-
Samsung Biologics to Acquire Peptide CDMO for 2.7 Trillion Won
A view of Samsung Biologics’ Plant 4. Photo courtesy of Samsung Biologics Samsung Biologics (207940.KS) is moving to…
#EuropeSays #Korea #KR #Samsung #biopharmaceuticals #contractmanufacturing #PeptideCDMO #PolyPeptideGroup #SamsungBiologics #SamsungGroup #Swisspharmaceuticalacquisition #tenderoffer
https://www.europesays.com/korea/91816/ -
Samsung Biologics to Acquire Swiss Peptide CDMO for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance
Samsung Biologics (207940.KS) announced on the 20th that it will acquire PolyPeptide Group, a global peptide contract development…
#EuropeSays #Korea #KR #Samsung #207940.KS #GLP-1 #JohnRim #obesitytreatment #PeptideCDMO #PeterWilden #PolyPeptideGroup #SamsungBiologics #SamsungGroup #Switzerland
https://www.europesays.com/korea/91608/ -
https://www.europesays.com/ch/105401/ Samsung Biologics to Acquire Swiss Peptide CDMO for approximately $1.8 Billion, Targeting Obesity Drug Market — BigGo Finance #207940KS #GLP1 #JohnRim #ObesityTreatment #PeptideCDMO #PeterWilden #PolyPeptideGroup #SamsungBiologics #Swiss #Switzerland